Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1F | P30939 | 17/20 | 1.00 |
| ▸ | HTR1D | P28221 | 2/20 | 0.73 |
| ▸ | HTR1E | P28566 | 2/20 | 0.73 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.73 |
| ▸ | DRD5 | P21918 | 1/20 | 0.73 |
| ▸ | HTR7 | P34969 | 1/20 | 0.73 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.73 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.73 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.73 |
| ▸ | HTR1A | P08908 | 1/20 | 0.54 |
| ▸ | HTR1B | P28222 | 1/20 | 0.54 |
| ▸ | HTR2A | P28223 | 1/20 | 0.54 |
| ▸ | HTR2C | P28335 | 1/20 | 0.54 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.54 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2531437 | 0.99 | HTR1F (0.98) | HTR1FHTR1DHTR1ECHRM5DRD5 | |
| SCHEMBL2540244 | 0.90 | HTR1F (0.81) | HTR1FHTR1DHTR1ECHRM5DRD5 | |
| Hydrochloric Acid SCHEMBL2535877 | 0.88 | HTR1F (0.79) | HTR1FHTR1DHTR1ECHRM5DRD5 | |
| SCHEMBL2531513 | 0.88 | HTR1F (0.78) | HTR1FHTR1DHTR1ECHRM5DRD5 | |
| SCHEMBL30909102 | 0.88 | HTR1F (0.78) | HTR1FHTR1DHTR1ECHRM5DRD5 | |
| SCHEMBL29031454 | 0.88 | HTR1F (0.78) | HTR1FHTR1DHTR1ECHRM5DRD5 | |
| SCHEMBL30909233 | 0.88 | HTR1F (0.78) | HTR1FHTR1DHTR1ECHRM5DRD5 | |
| SCHEMBL2539504 | 0.88 | HTR1F (0.78) | HTR1FHTR1DHTR1ECHRM5DRD5 | |
| SCHEMBL2535880 | 0.87 | HTR1F (0.78) | HTR1FHTR1DHTR1ECHRM5DRD5 | |
| SCHEMBL30909139 | 0.87 | HTR1F (0.78) | HTR1FHTR1DHTR1ECHRM5DRD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125645-A1 | METHODS AND PHARMACOLOGICAL AGENTS FOR INCREASING EXPANSION, ENGRAFTMENT OR IMMUNE OUTPUT OF HUMAN HEMATOPOIETIC STEM CELLS IN TRANSPLANTATION AND DISEASE SETTINGS | VALORISATION HSJ LP (CA) | 2026-05-07 | — | — | US | disclosed |
| WO-2024073845-A1 | METHODS AND PHARMACOLOGICAL AGENTS FOR INCREASING EXPANSION, ENGRAFTMENT OR IMMUNE OUTPUT OF HUMAN HEMATOPOIETIC STEM CELLS IN TRANSPLANTATION AND DISEASE SETTINGS | VALORISATION HSJ, LIMITED PARTNERSHIP (CA) | 2024-04-11 | — | — | WO | disclosed |
| US-20170044136-A1 | Pyridinoylpiperidines As 5-HT1F Agonists | LILLY CO ELI (US) | 2017-02-16 | — | — | US | disclosed |
| US-20170044136-A1 | Pyridinoylpiperidines As 5-HT1F Agonists | LILLY CO ELI (US) | 2017-02-16 | — | — | US | disclosed |
| US-20150376178-A1 | Pyridinoylpiperidines As 5-HT1F Agonists | ELI LILLY AND COMPANY | 2015-12-31 | — | — | US | disclosed |
| US-20150376178-A1 | Pyridinoylpiperidines As 5-HT1F Agonists | ELI LILLY AND COMPANY | 2015-12-31 | — | — | US | disclosed |
| US-8748459-B2 | Pyridinoylpiperidines as 5-HT1F agonists | ELI LILLY AND COMPANY (US) | 2014-06-10 | — | — | US | disclosed |
| US-20120329820-A1 | Pyridinoylpiperidines As 5-HT1F Agonists | ELI LILLY AND COMPANY (US) | 2012-12-27 | — | — | US | disclosed |
| US-20120329820-A1 | Pyridinoylpiperidines As 5-HT1F Agonists | ELI LILLY AND COMPANY (US) | 2012-12-27 | — | — | US | disclosed |
| US-8044207-B2 | Pyridinoylpiperidines as 5-HT1F agonists | ELI LILLY AND COMPANY (US) | 2011-10-25 | — | — | US | disclosed |
| US-20090209563-A1 | Pyridinoylpiperidines as 5-HT1F agonists | ELI LILLY AND COMPANY | 2009-08-20 | — | — | US | disclosed |
| US-20090209563-A1 | Pyridinoylpiperidines as 5-HT1F agonists | ELI LILLY AND COMPANY | 2009-08-20 | — | — | US | disclosed |
| US-20080300407-A1 | Pyridinoylpiperidines as 5-HT1F agonists | ELI LILLY AND COMPANY (IN) | 2008-12-04 | — | — | US | disclosed |
| US-20080300407-A1 | Pyridinoylpiperidines as 5-HT1F agonists | ELI LILLY AND COMPANY (IN) | 2008-12-04 | — | — | US | disclosed |
| US-20080300407-A1 | Pyridinoylpiperidines as 5-HT1F agonists | ELI LILLY AND COMPANY (IN) | 2008-12-04 | — | — | US | disclosed |
| US-7423050-B2 | Pyridinoylpiperidines as 5-HT1F agonists | ELI LILLY AND COMPANY (US) | 2008-09-09 | — | — | US | disclosed |
| US-7423050-B2 | Pyridinoylpiperidines as 5-HT1F agonists | ELI LILLY AND COMPANY (US) | 2008-09-09 | — | — | US | disclosed |
| US-7423050-B2 | Pyridinoylpiperidines as 5-HT1F agonists | ELI LILLY AND COMPANY (US) | 2008-09-09 | — | — | US | disclosed |
| EP-1492786-B1 | PYRIDINOYLPIPERIDINES AS 5-HT1F AGONISTS | LILLY CO ELI (US) | 2006-10-04 | — | — | EP | disclosed |
| US-20050222206-A1 | Pyridinoylpiperidines as 5-ht1f agonists | ELI LILLY AND COMPANY | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080300407-A1 | Pyridinoylpiperidines as 5-HT1F agonists | HTR1F, HTR1A, HTR1E | HTR1F 1/4885HTR1D 4/4885HTR1E 3/4885 |
| US-20260125645-A1 | METHODS AND PHARMACOLOGICAL AGENTS FOR INCREASING EXPANSION, ENGRAFTMENT OR IMMUNE OUTPUT OF HUMAN HEMATOPOIETIC STEM CELLS IN TRANSPLANTATION AND DISEASE SETTINGS | HTR1F, HTR1A, HTR1D | HTR1F 1/4885HTR1D 3/4885HTR1E 6/4885 |
| US-20120329820-A1 | Pyridinoylpiperidines As 5-HT1F Agonists | HTR1F, HTR1A, HTR1E | HTR1F 1/4885HTR1D 4/4885HTR1E 3/4885 |
| US-20170044136-A1 | Pyridinoylpiperidines As 5-HT1F Agonists | HTR1F, HTR1A, HTR1E | HTR1F 1/4885HTR1D 4/4885HTR1E 3/4885 |
| US-20050222206-A1 | Pyridinoylpiperidines as 5-ht1f agonists | HTR1F, HTR1A, HTR1E | HTR1F 1/4885HTR1D 4/4885HTR1E 3/4885 |
| US-20150376178-A1 | Pyridinoylpiperidines As 5-HT1F Agonists | HTR1F, HTR1A, HTR1E | HTR1F 1/4885HTR1D 4/4885HTR1E 3/4885 |
| US-20090209563-A1 | Pyridinoylpiperidines as 5-HT1F agonists | HTR1F, HTR1A, HTR1E | HTR1F 1/4885HTR1D 4/4885HTR1E 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.